Name: Latest research reports of Windlas Biotech Ltd. authored by Ashika Research and published by - Trendlyne research reports.
Item: Windlas Biotech Ltd.
Rating: 3
Author: Ashika Research

Windlas Biotech Ltd.

NSE: WINDLAS | BSE: 543329 | ISIN: INE0H5O01029 | Industry: Pharmaceuticals
| Slowing Down Stock

777.5500 -9.20 (-1.17%)

NSE Feb 19, 2026 15:31 PM

31.79% Fall from 52W High

Volume: 16,965

Windlas Biotech Ltd.

04 Aug 2021

777.55

-1.17%

Windlas Biotech Ltd. IPO Note

IPO Note: Windlas Biotech Ltd.

Ashika Research

5 each, (Comprising of fresh issue of 3,586,957 Equity Shares* (Rs. 165 cr.) and Offer for Sale of 5,142,067 Equity Shares (Rs. 236.5 cr.*) by Selling Shareholder)....

Windlas Biotech has lost -27.39% in the last 6 Months